The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
The Role of the Transcription Factor EGR1 in Cancer
Open accessAbstract
Early growth response factor 1 (EGR1) is a transcription factor that is mainly involved in the processes of tissue injury, immune responses, and fibrosis. Recent studies have shown that EGR1 is closely related to the initiation and progression of cancer and may participate in tumor cell proliferation, invasion, and metastasis and in tumor angiogenesis. Nonetheless, the specific mechanism whereby EGR1 modulates these processes remains to be elucidated. This review article summarizes possible mechanisms of action of EGR1 in tumorigenesis and tumor progression and may serve as a reference for clinical efficacy predictions and for the discovery of new therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sukhatme, V. P., Cao, X., Chang, L. C., Tsai-Morris, C.-H., Stamenkovich, D., Ferreira, P. C. P., Cohen, D. R., Edwards, S. A., Shows, T. B., Curran, T., et al. (1988) · Cell · doi:10.1016/0092-8674(88)90485-0 · Cited by 1,250
O'Donovan, K. J., Tourtellotte, W. G., Millbrandt, J., & Baraban, J. M. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01343-5 · Cited by 457
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling
Virolle, T., Adamson, E. D., Baron, V., Birle, D., Mercola, D., Mustelin, T., & de Belle, I. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-1124 · Cited by 399
Hepatocyte growth factor induces cell scattering through MAPK/Egr‐1‐mediated upregulation of Snail
Grotegut, S., von Schweinitz, D., Christofori, G., & Lehembre, F. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601213 · Cited by 363
Fahmy, R. G., Dass, C. R., Sun, L.-Q., Chesterman, C. N., & Khachigian, L. M. (2003) · Nature Medicine · doi:10.1038/nm905 · Cited by 361
Detection and characterization of cellular EGR-1 binding to its recognition site
Cao, X., Mahendran, R., Guy, G. R., & Tan, Y. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85286-9 · Cited by 197
Schwachtgen, J. L., Houston, P., Campbell, C., Sukhatme, V, & Braddock, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1404 · Cited by 193
Early Growth Response-1-dependent Apoptosis Is Mediated by p53
Nair, P., Muthukkumar, S., Sells, S. F., Han, S.-S., Sukhatme, V. P., & Rangnekar, V. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20131 · Cited by 176
Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis
Ji, R. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.001 · Cited by 166
EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis
Li, L., Ameri, A. H., Wang, S., Jansson, K. H., Casey, O. M., Yang, Q., Beshiri, M. L., Fang, L., Lake, R. G., Agarwal, S., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0873-8 · Cited by 158
Choi, B. H., Kim, C. G., Bae, Y., Lim, Y., Lee, Y. H., & Shin, S. Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5222 · Cited by 137
Early growth response 1--a transcription factor in the crossfire of signal transduction cascades.
Pagel, J.-I., & Deindl, E. (2011) · PubMed · Cited by 121
Krones-Herzig, A., Adamson, E., & Mercola, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2628034100 · Cited by 118
Is EGR1 a Potential Target for Prostate Cancer Therapy?
Gitenay, D., & Baron, V. T. (2009) · Future Oncology · doi:10.2217/fon.09.67 · Cited by 117
Calogero, A., Arcella, A., Gregorio, G. D., Porcellini, A., Mercola, D., Liu, C., Lombari, V., Zani, M., Giannini, G., Gagliardi, F., et al. (2001) · PubMed · Cited by 109
Pan, L., Matloob, A. F., Du, J., Pan, H., Dong, Z., Zhao, J., Feng, Y., Zhong, Y., Huang, B., & Lü, J. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07542.x · Cited by 106
Chen, H., Kuo, T., Tseng, C., Ma, J., Yang, S., Yen, C., Yang, C., Sung, S., & Su, J. (2016) · Hepatology · doi:10.1002/hep.28773 · Cited by 104
Transcriptional Regulation of EGR1 by EGF and the ERK Signaling Pathway in Prostate Cancer Cells
Gregg, J., & Fraizer, G. C. (2011) · Genes & Cancer · doi:10.1177/1947601911431885 · Cited by 103
Schmidt, K., Carroll, J. S., Yee, E., Thomas, D. D., Wert-Lamas, L., Neier, S. C., Sheynkman, G., Ritz, J., & Novina, C. D. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.101 · Cited by 103
A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells
Yu, J., Baron, V. T., Mercola, D., Mustelin, T., & Adamson, E. D. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402029 · Cited by 101
Lawson, M. A., Tsutsumi, R., Zhang, H., Talukdar, I., Butler, B. K., Santos, S. J., Mellon, P. L., & Webster, N. J. G. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0392 · Cited by 100
Kumbrink, J., Gerlinger, M., & Johnson, J. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511079200 · Cited by 98
The transcription factor Egr1 regulates the HIF‐1α gene during hypoxia
Sperandio, S., Fortin, J., Šášik, R., Robitaille, L., Corbeil, J., & de Belle, I. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20454 · Cited by 95
de Belle, I., Huang, R., Fan, Y., Liu, C., Mercola, D., & Adamson, E. D. (1999) · Oncogene · doi:10.1038/sj.onc.1202696 · Cited by 95
Lim, J. H., Park, J. W., Min, D. S., Chang, J., Lee, Y. H., Park, Y. B., Choi, K. S., & Kwon, T. K. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0576-9 · Cited by 95
ZnO nanoparticles induce TNF-α expression via ROS-ERK-Egr-1 pathway in human keratinocytes
Jeong, S. H., Kim, H. J., Ryu, H. J., Ryu, W. I., Park, Y.-H., Bae, H. C., Jang, Y., & Son, S. W. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.08.002 · Cited by 87
Chen, L., Wang, S., Zhou, Y., Wu, X., Entin, I., Epstein, J., Yaccoby, S., Xiong, W., Barlogie, B., Shaughnessy, J. D., et al. (2009) · Blood · doi:10.1182/blood-2009-03-210526 · Cited by 86
Snail collaborates with EGR-1 and SP-1 to directly activate transcription of MMP 9 and ZEB1
Wu, W., You, R.-I., Cheng, C.-C., Lee, M., Lin, T., & Hu, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-18101-7 · Cited by 85
Ionizing Radiation-inducible Apoptosis in the Absence of p53 Linked to Transcription Factor EGR-1
Ahmed, M. M., Sells, S. F., Venkatasubbarao, K., Fruitwala, S. M., Muthukkumar, S., Harp, C., Mohiuddin, M., & Rangnekar, V. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33056 · Cited by 84
Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors
Mayer, S. I., Rößler, O. G., Endo, T., Charnay, P., & Thiel, G. (2009) · Journal of Cell Science · doi:10.1242/jcs.048272 · Cited by 83
The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function
Wan, L., Chen, M., Cao, J., Dai, X., Yin, Q., Zhang, J., Song, S.-J., Lu, Y., Liu, J., Inuzuka, H., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0647 · Cited by 75
Cheng, J.-C., Chang, H.-M., & Leung, P. C. K. (2012) · Oncogene · doi:10.1038/onc.2012.127 · Cited by 72
MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway
Brown, K. C., Lau, J. K., Dom, A. M., Witte, T. R., Luo, H., Crabtree, C. M., Shah, Y. H., Shiflett, B. S., Marcelo, A. J., Proper, N. A., et al. (2011) · Angiogenesis · doi:10.1007/s10456-011-9246-9 · Cited by 70
Self-citationSustained Expression of Early Growth Response Protein-1 Blocks Angiogenesis and Tumor Growth
Lucerna, M., Pomyje, J., Mechtcheriakova, D., Kadl, A., Грубер, Ф., Bilban, M., Sobanov, Y., Schabbauer, G., Breuss, J. M., Wagner, O. F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2732 · Cited by 69
Shimoyamada, H., Yazawa, T., Sato, H., Okudela, K., Ishii, J., Sakaeda, M., Kashiwagi, K., Suzuki, T., Mitsui, H., Woo, T., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091164 · Cited by 68
Physical interaction between p53 and primary response gene Egr-1.
Liu, J., Grogan, L., Nau, M., Allegra, C. J., Chu, E., & Wright, J. J. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.4.863 · Cited by 66
Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors
Thiel, G., & Rößler, O. G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.029 · Cited by 66
Disruption of Cooperation Between Ras and MycN in Human Neuroblastoma Cells Promotes Growth Arrest
Yaari, S., Jacob‐Hirsch, J., Amariglio, N., Haklai, R., Rechavi, G., & Kloog, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2071 · Cited by 65
Xiao, D., Chinnappan, D., Pestell, R. G., Albanese, C., & Weber, H. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1830 · Cited by 61
Das, A., Damodaran, C., Dey, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008454200 · Cited by 60
Yoon, Y. J., Kim, D., Yoon, C. M., Park, J., Kim, Y.-K., Roh, T., & Gho, Y. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115170 · Cited by 57
Park, Y.-J., Kim, E. K., Bae, J. Y., Moon, S., & Kim, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.021 · Cited by 53
Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC
Wang, W., Xiong, Y., Ding, X., Wang, L., Zhao, Y., Fei, Y., Zhu, Y., Shen, X., Tan, C., & Liang, Z. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1054-x · Cited by 53
Kim, S. O., Kwon, J. I., Jeong, Y. K., Kim, G., Kim, N. D., & Choi, Y. H. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70103 · Cited by 52
Rockel, J. S., Bernier, S. M., & Leask, A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2595 · Cited by 52
Wang, C., Husain, K. M., Zhang, A., Centeno, B. A., Chen, D., Tong, Z., Sebti, S. M., & Malafa, M. P. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.02.008 · Cited by 51
Vaish, V., Piplani, H., Rana, C., Vaiphei, K., & Sanyal, S. N. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1593-y · Cited by 50
Molecular Basis for the Induction of an Angiogenesis Inhibitor, Thrombospondin-1, by 5-Fluorouracil
Zhao, H., Ooyama, A., Yamamoto, M., Ikeda, R., Haraguchi, M., Tabata, S., Furukawa, T., Che, X., Zhang, S., Oka, T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6496 · Cited by 49
Wang, L.-F., Liu, Y.-S., Yang, B., Li, P., Cheng, X.-S., Xiao, C.-X., Liu, J.-J., Li, S., Ren, J.-L., & Guleng, B. (2017) · Oncogene · doi:10.1038/onc.2017.359 · Cited by 47
Shin, D. Y., Kim, G., Kim, N., Jung, J. H., Kim, S., Kang, H. W., & Choi, Y. H. (2008) · Oncology Reports · doi:10.3892/or.19.2.517 · Cited by 46
Wu, Y., Li, D., Wang, Y., Liu, X., Zhang, Y., Qu, W., Chen, K., Francisco, N. M., Feng, L., Huang, X., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00211 · Cited by 46
Maeda, M., Murakami, Y., Watari, K., Kuwano, M., Izumi, H., & Ono, M. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.01.009 · Cited by 44
Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
Feng, Y., Su, Y., Lin, S.-F., Lin, P., Wu, C., Tung, C.-L., Li, C., Shieh, G.-S., & Shiau, A. (2019) · BMC Cancer · doi:10.1186/s12885-019-6014-5 · Cited by 43
Kundumani‐Sridharan, V., Niu, J., Wang, D., Quyền, Đ. V., Zhang, Q., Singh, N. K., Subramani, J., Karri, S., & Rao, G. N. (2010) · Blood · doi:10.1182/blood-2009-09-241802 · Cited by 42
Shin, S. Y., Kim, H., Jang, H.-H., Hwang, Y.-J., Choe, J., Kim, J.-B., Lim, Y., & Lee, Y. H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.016 · Cited by 41
Ryu, J., Choe, S. S., Ryu, S.-H., Park, E., Lee, B. W., Kim, T. K., Ha, C. H., & Lee, S.-W. (2016) · Oncotarget · doi:10.18632/oncotarget.13809 · Cited by 40
Liu, P., Xu, B., Li, J., & Lu, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.094 · Cited by 38
Zhao, H., Ooyama, A., Yamamoto, M., Ikeda, R., Haraguchi, M., Tabata, S., Furukawa, T., Che, X., Iwashita, K., Oka, T., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.045 · Cited by 37
Resveratrol is an effective inducer of CArG-driven TNF-α gene therapy
Bickenbach, K. A., Veerapong, J., Shao, M. Y., Mauceri, H. J., Posner, M. C., Kron, S. J., & Weichselbaum, R. R. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701103 · Cited by 36
Estrogen receptor β stimulates Egr-1 transcription via MEK1/Erk/Elk-1 cascade in C6 glioma cells
Kim, J.-H., Jeong, I.-Y., Lim, Y., Lee, Y.-H., & Shin, S.-Y. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.7.452 · Cited by 35
Spencer, J. A., Major, M. L., & Misra, R. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.3977 · Cited by 28
Shan, L., Song, Y.-G., Su, D., Liu, Y., Shi, X., & Si-jing, L. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.4137 · Cited by 22
Suda, M., Shimizu, I., Yoshida, Y., Hayashi, Y., Ikegami, R., Katsuumi, G., Wakasugi, T., Yoshida, Y., Okuda, S., Soga, T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182422 · Cited by 22
Egr-1 regulates the transcription of the BRCA1 gene by etoposide
Shin, S. Y., Kim, C. G., & Lee, Y. H. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.2.202 · Cited by 19
Radiation to control transgene expression in tumors
Marignol, L. H., Coffey, M. A., Hollywood, D. P., & Lawler, M. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.7.4477 · Cited by 19
Liu, P., Li, J., Lu, H., & Xu, B. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802588352 · Cited by 19
S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway
Yang, W., Nam, K., Ju, J., Lee, K., Oh, S., & Shin, I. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.06.007 · Cited by 14
Snyder, R. O., & Thekkumkara, T. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0154 · Cited by 13
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs
Naoum, G. E., Zhu, Z. B., Buchsbaum, D. J., Curiel, D. T., & Arafat, W. O. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0140-y · Cited by 13
Early growth response 1 promoted the invasion of glioblastoma multiforme by elevating HMGB1
Kai, D. U., Wu, X., Ji, X., LIANG, N., & Zheng, L. I. (2022) · Journal of Neurosurgical Sciences · doi:10.23736/s0390-5616.20.05107-3 · Cited by 13
Kim, J., Kang, S., Lee, H., Choi, S., & Hong, S. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000501 · Cited by 12
Chen, J., Zhan, Y., Xu, J., Wang, Y., & Gao, Q. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00392-3 · Cited by 12
Zhong, J., Wang, H., Yu, J., Zhang, J.-H., Wang, S., Yang, X., & Su, W. (2017) · Cancer Biomarkers · doi:10.3233/cbm-161710 · Cited by 9
Expression and clinical significance of EGR-1 and PTEN in the pituitary tumors of elderly patients
Sun, S., Fang, X.-M., Li, Y., Wang, Q., & Li, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.6375 · Cited by 7
Cited by
Arora, R., Cao, C., Kumar, M., Sinha, S., Chanda, A., McNeil, R., Samuel, D., Arora, R. K., Matthews, T. W., Chandarana, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40271-4 · Cited by 325
Archana, C. A., Sekar, Y. S., Suresh, K. P., Subramaniam, S., Sagar, N., Rani, S., Anandakumar, J., Pandey, R. K., Barman, N. N., & Patil, S. S. (2024) · Genes · doi:10.3390/genes15040426 · Cited by 5
Metadata
- Authors
- Wang, B., Guo, H., Yu, H., Chen, Y., Xu, H., & Zhao, G.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2021-03-24
- Volume
- 11
- Pages
- 642547-642547
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3136819357
- Cited by
- 261
- References
- 74
- FWCI
- 25.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.